Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery

Background Patients often fail to stop clopidogrel appropriately before non‐cardiac surgery. Thromboelastography platelet mapping (TEG‐PM) can be used to measure the percentage adenosine 5′‐diphosphate platelet receptor inhibition (ADP‐PRI) by clopidogrel in these patients. Methods This prospective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of surgery 2014-10, Vol.101 (11), p.1383-1390
Hauptverfasser:	Kasivisvanathan, R., Abbassi-Ghadi, N., Kumar, S., Mackenzie, H., Thompson, K., James, K., Mallett, S. V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Case-Control Studies Erythrocyte Transfusion - statistics & numerical data Female Humans Male Middle Aged Platelet Aggregation Inhibitors - adverse effects Postoperative Care Postoperative Complications - chemically induced Postoperative Hemorrhage - chemically induced Prospective Studies Purinergic P2Y Receptor Antagonists - adverse effects Receptors, Purinergic P2Y12 - metabolism Reoperation - statistics & numerical data Risk Factors Thrombelastography - methods Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!